Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Mid-range Performer
189.3600 -3.46 (-1.79%)
NSE Aug 26, 2025 15:31 PM
Volume: 2.7M
 

189.36
-1.79%
ICICI Securities Limited
Piramal Pharma’s Q1FY25 result was driven by better traction in innovative CDMO portfolio (50% of CDMO sales). Q1 is a seasonally weak quarter due to which its margins (10.5% in Q1FY25 vs 20.8% in Q4FY24) are volatile.
Piramal Pharma Ltd. is trading below all available SMAs
More from Piramal Pharma Ltd.
Recommended